Home » Newsletters » BioWorld

BioWorld

March 20, 1992

View Archived Issues

LACKLUSTER IPO RAISES $20M FOR TELIOS

FDA APPROVES QUIDEL OVULATION TEST

DEPRENYL RESEARCH UNHAPPY WITH ANALYST

WARRANT EXERCISE RAISES $15.5M

ENGLISH COMPANY ENTERS HEPATITIS B MARKET

CALGENE SELLS 2.3M SHARES

VIMRX CLEARED TO RESUME AIDS TRIALS

LAWMAKER SAYS ADMINISTRATION PUSHING FDA

POWERFUL NEW DRUG DISCOVERY TECHNOLOGY

GILEAD SHARES BOOSTED BY FIRST IND